Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17550530 | 0.88 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL24805105 | 0.88 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL17550504 | 0.84 | MEN1 (0.30) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL19601038 | 0.84 | ALDH1A1 (0.39) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL17548717 | 0.82 | ALDH1A1 (0.37) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL19606976 | 0.82 | ALDH1A1 (0.45) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL19608811 | 0.81 | ALDH1A1 (0.31) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 | |
| SCHEMBL17550517 | 0.81 | ALDH1A1 (0.39) | ALDH1A1KMT2AMEN1NPSR1GAA | |
| SCHEMBL16946306 | 0.81 | — | — | |
| SCHEMBL19601025 | 0.81 | CYP17A1 (0.43) | ALDH1A1KMT2AMEN1CYP17A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230004084-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230004084-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | H1-10, H1-0, H1-4 | ALDH1A1 518/4885KMT2A 1366/4885MEN1 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.